RDEA Financial Facts

Total operating expenses: 42.49M
Research and development: 36.8M
See Full Income Statement

Prepaids and other current assets: 7.04M
Current portion of long-term debt: 76K
See Full Balance Sheet

Ardea Biosciences, Inc. (RDEA) Earnings

  |   Expand Research on RDEA
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -29.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -6.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/9/12 Q411 -$1.15-$0.86 -$0.29$1.7M$1.85M N/A Details
5/7/12 Q112 -$1.25-$0.98 -$0.27$1.5M$3M N/A Details
11/4/11 Q311 -$0.84-$0.67 -$0.17$1.7M$1.95M N/A Details
8/5/11 Q211 -$0.68-$0.52 -$0.16$2.2M$2.69M N/A Details
5/6/11 Q111 -$0.59-$0.50 -$0.09$1.77M$3.86M N/A Details
3/11/11 Q410 -$0.03-$0.59 +$0.56$17.3M$4.04M N/A Details